Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|April 22, 2015
Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 InducersXinlai Cheng, Eleni Dimou, Hamed Alborzinia, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Stem Cells International|March 15, 2018
Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived CardiomyocytesZhihan Zhao, Huan Lan, Ibrahim El-Battrawy, et al.
Plos One|March 12, 2015
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanomaLisa Zimmer, Julia Vaubel, Peter Mohr, et al.
Journal of the American Heart Association|March 26, 2018
Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesIbrahim El-Battrawy, Huan Lan, Lukas Cyganek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanomaCaroline Robert, Keith Flaherty, Paul Nathan, et al.
Pigment Cell & Melanoma Research|April 1, 2015
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based modelLionel Larribere, Huizi Wu, Daniel Novak, et al.
Translational Oncology|December 19, 2024
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibitionYasmin F Melzer, Nadine L Fergen, Christian Mess, et al.
Scientific Reports|April 6, 2019
Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytesKatherine Sattler, Ibrahim El-Battrawy, Zhihan Zhao, et al.
Journal of Translational Medicine|November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanomaLisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|April 22, 2015
Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 InducersXinlai Cheng, Eleni Dimou, Hamed Alborzinia, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Stem Cells International|March 15, 2018
Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived CardiomyocytesZhihan Zhao, Huan Lan, Ibrahim El-Battrawy, et al.
Plos One|March 12, 2015
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanomaLisa Zimmer, Julia Vaubel, Peter Mohr, et al.
Journal of the American Heart Association|March 26, 2018
Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesIbrahim El-Battrawy, Huan Lan, Lukas Cyganek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanomaCaroline Robert, Keith Flaherty, Paul Nathan, et al.
Pigment Cell & Melanoma Research|April 1, 2015
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based modelLionel Larribere, Huizi Wu, Daniel Novak, et al.
Translational Oncology|December 19, 2024
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibitionYasmin F Melzer, Nadine L Fergen, Christian Mess, et al.
Scientific Reports|April 6, 2019
Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytesKatherine Sattler, Ibrahim El-Battrawy, Zhihan Zhao, et al.
Journal of Translational Medicine|November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanomaLisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Pageof 28